Proton-pump inhibitors among adults: a nationwide drug-utilization study
Open Access
- 1 January 2018
- journal article
- research article
- Published by SAGE Publications in Therapeutic Advances in Gastroenterology
- Vol. 11
Abstract
The use of proton-pump inhibitors (PPIs) has grown worldwide, and there are concerns about increased unsubstantiated long-term use. The aim of the study was to describe the real-world use of PPIs over the past decade in an entire national population. This was a nationwide population-based drug-utilization study. Patterns of outpatient PPI use among adults in Iceland between 2003 and 2015 were investigated, including annual incidence and prevalence, duration of use, and dose of tablet used (lower versus higher), as well as the proportion of PPI use attributable to gastroprotection. We observed 1,372,790 prescription fills over the entire study period, of which 95% were for higher-dose PPIs. Annual incidence remained stable across time (3.3–4.1 per 100 persons per year), while the annual prevalence increased from 8.5 per 100 persons to 15.5 per 100 persons. Prevalence increased with patient age and was higher among women than men. Duration of treatment increased with patients’ age (36% of users over 80 years remained on treatment after 1 year compared with 13% of users aged 19–39 years), and was longer among those initiating on a higher dose compared with a lower dose. The proportion of PPI users concurrently using nonsteroidal anti-inflammatory drugs decreased over the study period, while the proportion concurrently using acetylsalicylic acid, oral anticoagulants, or platelet inhibitors increased. In this nationwide study, a considerable increase in overall outpatient use of PPIs over a 13-year period was observed, particularly among older adults. Patients were increasingly treated for longer durations than recommended by clinical guidelines and mainly with higher doses.Keywords
Funding Information
- The Icelandic research fund (152715-053)
- the University of Iceland Research Fund (HI16090004)
This publication has 37 references indexed in Scilit:
- Study of Gender Differences in Proton Pump Inhibitor Dose Requirements for GERDJournal of Clinical Gastroenterology, 2017
- Association Between Proton Pump Inhibitors and Microscopic ColitisAnnals of Pharmacotherapy, 2016
- The Association of Drugs With Severity and Specific Causes of Acute Lower Gastrointestinal BleedingJournal of Clinical Gastroenterology, 2016
- Proton-pump inhibitors and risk of fractures: an update meta-analysisOsteoporosis International, 2015
- Proton pump inhibitors linked to hypomagnesemia: a systematic review and meta-analysis of observational studiesRenal Failure, 2015
- Nonsteroidal Anti-inflammatory Drugs, Proton Pump Inhibitors, and Gastrointestinal Injury: Contrasting Interactions in the Stomach and Small IntestineMayo Clinic Proceedings, 2014
- Overutilization of proton-pump inhibitors: what the clinician needs to knowTherapeutic Advances in Gastroenterology, 2012
- The Nordic Countries as a Cohort for Pharmacoepidemiological ResearchBasic & Clinical Pharmacology & Toxicology, 2010
- Symptoms in patients on long‐term proton pump inhibitors: prevalence and predictorsAlimentary Pharmacology & Therapeutics, 2009
- Continuation of Proton Pump Inhibitors from Hospital to CommunityPharmacy World & Science, 2006